Snapshot from Jun 28, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Levi Garraway / Roche

Levi Garraway & Roche

1 shared events · Importance 4 · Last updated Jun 12, 2026

Importance
4
Shared Events
1
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (1)
55
Regulatory
FDA accepts Roche Tecentriq sBLA
Levi Garraway: Levi Garraway>>>, Roche>>>'s Chief Medical Officer, commented on the significance of the filing acceptance for Atezolizumab>>>.
Roche: Roche's supplemental Biologics License Application for Atezolizumab has been accepted by the United States — Food and Drug Administration>>> for Priority Review, potentially leading to a new standard of care for stage III colon cancer and boosting its market position.
Jun 11, 2026 · 6 articles
NEWSDESK
Explore this relationship live

Track how Levi Garraway and Roche interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.